{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:HMOX",
      "entity_text" : "heme oxygenase",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P35354",
      "entity_text" : "COX-2",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "XREF_BIBR, XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR - XREF_BIBR Similar results from in vitro experiments have indicated that Supartz FX suppressed the expression of collagenases (MMP-1, -3, and -13), aggrecanases (ADAMTS4 and 5), and COX-2, and promoted the expression of antioxidant enzymes (heme oxygenase [HO]-1, NAD (P) H : quinone oxidoreductase [NQO]-1, glutathione peroxidase [GPX]-1, catalase, and superoxide dismutase [SOD] 1).",
  "reading_complete" : "2020-08-04T21:59:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T21:54:37Z",
  "trigger" : "promoted",
  "evidence" : [ "COX-2, and promoted the expression of antioxidant enzymes (heme oxygenase" ],
  "pmc_id" : "5724672",
  "score" : 0
}